HUBUNGAN LAMA PENGGUNAAN OBAT ARV TERHADAP KADAR HEMOGLOBIN PADA PENDERITA HIV/AIDS DI POLI VCT RSUD PROF. DR. SOEKANDAR KABUPATEN MOJOKERTO
Abstract
Antiretroviral (ARV) therapy was undertaken with HIV/AIDS by took medication for life, to suppress the amount of virus. Most people took antiretroviral (ARV) drugs had some side effects, one of which decreased in hemoglobin (Hb), which was influenced by factors duration of therapy and CD4 levels. As a result of long use of antiretroviral (ARV) drugs by the side effects that cause a decrease in hemoglobin. The research objective was to determine the relationship of long used of ARV (Antiretroviral) on levels of hemoglobin in people with HIV / AIDS. The research design corelation analytical with cross sectional approach. Entired population HIV/AIDS patients undergoing antiretroviral therapy in Polyclinic VCT at Prof. Dr. Soekandar Hospital District Mojokerto regency as many as 65 respondents. Samples of 25 respondents took by purposive sampling. Old data retrieval use of ARV drugs by used observations of medical records and hemoglobin concentration used check tool hemoglobin (Hb Quick Chek) and secondary data. Test data analysis using the Spearman rho shows ρ (0.002) < α (0.05), it means that there is a long-standing relationship to the use of ARV drugs hemoglobin levels. Decreases in hemoglobin may occur due to antiretroviral drugs tend to inhibit the enzyme reverse transcriptase and cause damage to the spinal cord so that hemoglobin in the blood is very low which leads to anemia. One way to suppress the occurrence of side effects can be done by taking supplements that can increase the levels of hemoglobin in the blood.
Downloads
The authors who publish this journal agree to the following requirements:
- The author retains the copyright and gives the journal rights regarding the first publication with the work being simultaneously licensed below Creative Commons Attribution ShareAlike License which allows others to share the work with an acknowledgment of the author's work and early publications in this journal.
- Authors can include separate additional contractual arrangements for the non-exclusive distribution of the journal's published version (for example, send it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this Journal.
- Authors are permitted and encouraged to post their work online (e.g., at an institutional repository or on their website) before and during the submission process, as this can lead to productive exchanges, as well as excerpts of previously published works.